A district judge recently nixed the HHS rule that certain drugs prices be included in TV ads, saying HHS overstepped its authority in issuing such a requirement. The rule, part of the President’s blueprint to lower drug prices and increase transparency, was scheduled to take effect this month.
“Neither the Act’s text, structure, nor context evince an intent by Congress to empower HHS to issue a rule that compels drug manufacturers to disclose list prices. The Rule is therefore invalid,” District Judge Amit P. Mehta wrote in his July 8 (Read more...)
Uncategorized